Results 351 to 360 of about 104,116 (405)
Some of the next articles are maybe not open access.
American Journal of Psychiatry, 2022
OBJECTIVE Extensive exposure to prescription-type opioids has resulted in major harm worldwide, calling for better-adapted approaches to opioid agonist therapy.
Didier Jutras-Aswad +14 more
semanticscholar +1 more source
OBJECTIVE Extensive exposure to prescription-type opioids has resulted in major harm worldwide, calling for better-adapted approaches to opioid agonist therapy.
Didier Jutras-Aswad +14 more
semanticscholar +1 more source
Impact of COVID-19 Telehealth Policy Changes on Buprenorphine Treatment for Opioid Use Disorder.
American Journal of Psychiatry, 2022OBJECTIVE The authors examined the impact of COVID-19-related policies reducing barriers to telehealth delivery of buprenorphine treatment for opioid use disorder (OUD) on buprenorphine treatment across different modalities (telephone, video, and in ...
L. Lin +3 more
semanticscholar +1 more source
Pain and Therapy, 2020 Buprenorphine is a Schedule III opioid analgesic with unique pharmacodynamic and pharmacokinetic properties that may be preferable to those of Schedule II full μ-opioid receptor agonists.
Jeffrey A Gudin
exaly +2 more sources
The effects of buprenorphine in buprenorphine-maintained volunteers
Psychopharmacology, 1997Buprenorphine is a mu opioid partial agonist currently used as an analgesic, and being developed for the treatment of opioid dependence. The purpose of this study was to determine the abuse liability of parenteral buprenorphine in volunteers maintained on daily sublingual (SL) buprenorphine (8 mg).
Eric C. Strain +4 more
openaire +3 more sources
Buprenorphine Treatment for Opioid Use Disorder: An Overview
CNS Drugs, 2019 Matisyahu Shulman
exaly +2 more sources
The radioimmunoassay of buprenorphine
European Journal of Clinical Pharmacology, 1980Antisera to buprenorphine were obtained in rabbits immunised with 3-0-carboxymethylbuprenorphine and N-hemisuccinyl-norbuprenorphine conjugated to bovine serum albumin. Using the latter antiserum and tritium labelled buprenorphine a radioimmunoassay have good accuracy and precision was developed for concentrations as low as 50 picograms in 1 ml of ...
M. R. D. Bennett +6 more
openaire +3 more sources
Injection of buprenorphine and buprenorphine/naloxone tablets in Malaysia
Drug and Alcohol Dependence, 2010Buprenorphine maintenance is efficacious for treating opioid dependence, but problems with diversion and misuse of buprenorphine (BUP) may limit its acceptability and dissemination. The buprenorphine/naloxone combination tablet (BNX) was developed to reduce potential problems with diversion and abuse.
Richard S. Schottenfeld +3 more
openaire +2 more sources
Drug and Alcohol Dependence, 1985
Buprenorphine is a mixed agonist-antagonist with high affinity at both mu and kappa opiate receptors. Its pharmacological profile is determined primarily by partial agonism at mu-receptors and unusually slow kinetics at these receptors. Its intrinsic activity is such that in nearly all clinical situations it is as effective an analgesic as morphine ...
openaire +2 more sources
Buprenorphine is a mixed agonist-antagonist with high affinity at both mu and kappa opiate receptors. Its pharmacological profile is determined primarily by partial agonism at mu-receptors and unusually slow kinetics at these receptors. Its intrinsic activity is such that in nearly all clinical situations it is as effective an analgesic as morphine ...
openaire +2 more sources
Blockade of hydromorphone effects by buprenorphine/naloxone and buprenorphine
Psychopharmacology, 2001Buprenorphine is an opioid agonist-antagonist used in the treatment of opioid dependence. Naloxone has been combined with buprenorphine to decrease the parenteral abuse potential of buprenorphine. This addition of naloxone may also confer further opioid blockade efficacy.To test the opioid blockade efficacy of sublingual buprenorphine/naloxone versus ...
Sharon L. Walsh +2 more
openaire +3 more sources
Low Dose Initiation of Buprenorphine: A Narrative Review and Practical Approach
Journal of addiction medicine, 2021Low dose buprenorphine initiation, is an alternative method of initiating buprenorphine in which the starting dose is very low and gradually increased to therapeutic levels over a period of days.
Shawn M Cohen +5 more
semanticscholar +1 more source